Skip to main content
Veterinary Medicines

ANTOX 9 max

Authorised
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, toxoid
  • Clostridium novyi, strain 754, toxoid
  • Clostridium novyi, type B, strain 34, toxoid
  • Clostridium septicum, strain 1098, Inactivated
  • Clostridium perfringens, type D, strain 98, toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type A, strain 28, toxoid

Product identification

Medicine name:
АНТОКС 9 макс
ANTOX 9 max
Active substance:
  • Clostridium sordellii, toxoid
  • Clostridium tetani, toxoid
  • Clostridium chauvoei, toxoid
  • Clostridium novyi, strain 754, toxoid
  • Clostridium novyi, type B, strain 34, toxoid
  • Clostridium septicum, strain 1098, Inactivated
  • Clostridium perfringens, type D, strain 98, toxoid
  • Clostridium perfringens, type C, beta toxoid
  • Clostridium perfringens, type A, strain 28, toxoid
Target species:
  • Cattle
  • Sheep
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Clostridium sordellii, toxoid
    1.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium tetani, toxoid
    1.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium chauvoei, toxoid
    5.00
    billion colony forming units
    /
    1.00
    Dose
  • Clostridium novyi, strain 754, toxoid
    6000.00
    Decimal potentisation
    /
    1.00
    Dose
  • Clostridium novyi, type B, strain 34, toxoid
    6000.00
    Decimal potentisation
    /
    1.00
    Dose
  • Clostridium septicum, strain 1098, Inactivated
    5.00
    billion colony forming units
    /
    1.00
    Dose
  • Clostridium perfringens, type D, strain 98, toxoid
    5.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium perfringens, type C, beta toxoid
    10.00
    international unit(s)
    /
    1.00
    Dose
  • Clostridium perfringens, type A, strain 28, toxoid
    0.50
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
    • Sheep
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AB01
  • QI04AB01
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Mintech Co EOOD
Marketing authorisation date:
Manufacturing sites for batch release:
  • Mintech Co EOOD
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-3086
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/06/2022

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 8/06/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."